Concepedia

G Schwab

GS

Statistics

Publications

18

Citations

2.7K

H-Index

17

Active since

1987

Affiliations

Amgen (United States)(Current)

National Cancer Institute

National Institutes of Health

Amgen (Germany)

G Schwab is an author at Amgen (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

1987–2010

18

Publications

18

A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1

Reino Heikkilä, G Schwab, Eric Wickstrom et al. · Nature · 1987 · 691 citations

Life Sciences, Genetics, Molecular Biology +14

Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy

Eileen Johnston, Jeffrey Crawford, Susan Blackwell et al. · Journal of Clinical Oncology · 2000 · 268 citations

Medicine, Oncology, Pharmacology +17

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

Norbert Schmitz, Andrea Bacigalupo, Dirk Hasenclever et al. · Bone Marrow Transplantation · 1998 · 264 citations

Medicine, Hematology, Immunology +15

A new form of Filgrastim with sustained duration in vivo and enhanced ability to mobilize PBPC in both mice and humans

Graham Molineux, Olaf Kinstler, Bob Briddell et al. · Experimental Hematology · 1999 · 243 citations

Pharmacy, Pharmacology, Cell Therapy +1

Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.

Luke Whitesell, S D Shifrin, G Schwab et al. · PubMed · 1992 · 176 citations

Medicine, Oncology, Pharmacology +15

1–5 of 18